Citation Impact
Citing Papers
Breast cancer
2019 Standout
Gender variations in clinical pain experience
1996 Standout
Pain in gynecologic practice
1978
Breast cancer
2016 Standout
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
2017
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Ki67 assessment in breast cancer: an update
2017
Sarcopenia
2019 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
2016
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
2015
Works of Bianca Lederer being referenced
Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study
2014
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
2015
Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
2014
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study
2016
Abstract S1-09: Evaluation of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarker in different subtypes of breast cancer treated with neoadjuvant therapy - A metaanalysis of 3771 patients
2017
[Endometriosis of the intestine].
1965
Relationship of omission of adjuvant radiotherapy to outcomes of locoregional control and disease-free survival in patients with or without pCR after neoadjuvant chemotherapy for breast cancer: A meta-analysis on 3481 patients from the Gepar-trials.
2015